Daniel Turyn Selected Research

Daniel Turyn Research Topics

Disease

11	Insulin Resistance 12/2012 - 09/2004
4	Hypertension (High Blood Pressure) 12/2009 - 08/2006
4	Hyperinsulinism (Hyperinsulinemia) 12/2009 - 03/2002
3	Neoplasms (Cancer) 04/2013 - 03/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2009 - 08/2006
2	Proteinuria 06/2012 - 01/2011
2	Inflammation (Inflammations) 06/2012 - 05/2009
2	Fibrosis (Cirrhosis) 06/2012 - 03/2010
2	Hypertriglyceridemia 12/2009 - 02/2009
1	Carcinogenesis 01/2017
1	Infarction (Infarctions) 06/2014
1	Ischemia 06/2014
1	Hypoxia (Hypoxemia) 06/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2012
1	Type 2 Diabetes Mellitus (MODY) 06/2012
1	Breast Neoplasms (Breast Cancer) 01/2012
1	Stroke (Strokes) 01/2011
1	Body Weight (Weight, Body) 03/2010
1	Hyperglycemia 12/2009
1	Hypercholesterolemia 12/2009
1	Obesity 05/2009
1	Hepatocellular Carcinoma (Hepatoma) 08/2008
1	Hyperplasia 08/2008
1	Hypertrophy 08/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2007

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 12/2009 - 09/2004
5	Growth Hormone (Somatotropin)IBA 01/2017 - 10/2005
5	AngiotensinsIBA 06/2012 - 08/2007
4	Insulin ReceptorIBA 12/2009 - 10/2005
4	Phosphotransferases (Kinase)IBA 05/2009 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 10/2005
3	angiotensin I (1-7)IBA 06/2012 - 02/2009
3	Irbesartan FDA LinkGeneric 12/2009 - 08/2006
3	Serine (L-Serine)FDA Link 05/2009 - 10/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2012 - 12/2009
2	CreatinineIBA 06/2012 - 01/2011
2	Epidermal Growth Factor (EGF)IBA 02/2012 - 03/2010
2	FructoseIBA 03/2010 - 02/2009
2	Angiotensin IIIBA 12/2009 - 08/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2009 - 10/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 08/2008 - 10/2005
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	triphenyltetrazoliumIBA 06/2014
1	vasectrin I (VS I)IBA 06/2014
1	Clonidine (ST 155)FDA LinkGeneric 06/2014
1	Prazosin (Minipress)FDA LinkGeneric 06/2014
1	Glycogen Synthase KinasesIBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 06/2012
1	Thiobarbituric Acid Reactive SubstancesIBA 06/2012
1	Lipocalin-2IBA 06/2012
1	CatalaseIBA 06/2012
1	Superoxide DismutaseIBA 06/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	SaltsIBA 01/2011
1	nephrinIBA 01/2011
1	Collagen Type III (Type III Collagen)IBA 03/2010
1	Insulin Receptor Substrate ProteinsIBA 12/2009
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2009
1	I-kappa B KinaseIBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	CytokinesIBA 10/2005
1	Glucose (Dextrose)FDA LinkGeneric 01/2005
1	bovine growth hormoneIBA 09/2004
1	Phospho-Specific AntibodiesIBA 09/2004
1	LipidsIBA 09/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2002

Therapy/Procedure

1	Ischemic Postconditioning 06/2014